Ovarian Cancer Survival Rates Improve in the UK

.

Cancer Research UK

Cancer Research UK recently announced that ovarian cancer survival rates in the country have doubled over the past three decades. The figures released on Wednesday were related to the figures for England and Wales.

According to the charity group, five year survival rates for people suffering from ovarian cancer rose to the present rate of 41% from 21% in the early 1970s. Cancer Research UK further informed that the improvement in survival rates meant that 1,000 more women survived ovarian cancer every year for a period of at least five years.

Despite the promising outcome of the study, the charity group opined that a lot of improvement can be made to help improve survival rates for women diagnosed with the condition in advanced stages. Meanwhile, the better survival rates are being seen as a result of better availability of treatment for the condition.

It needs to be pointed out that 6,500 cases of ovarian cancer are diagnosed every year. Apart from that, it also resulted in the death of 4,400 women in 2008 in the UK. Ovarian cancer has been referred to the ‘silent killer’, as its symptoms are not easy to diagnose and on a majority of occasions the condition is detected in advanced stages.

Talking about the trend, Dr. James Brenton, from the Cambridge Research Institute of Cancer Research UK, said: "These latest figures show improvements in treatment, such as centralization of ovarian cancer surgery and uniform access to chemotherapy, are making a difference in helping more women survive ovarian cancer, particularly those who are diagnosed earlier".


Latest News

Minimum Wage for Tipped Workers Raised in New York
Office Depot and Home Depot Reports Better Than Expected Earnings Results
Attorney General Eric Schneiderman investigating the Selection Process of Casino
Barack Obama Calls for Stricter Standards for Brokers Advising on Saving Plans
Chefs of SoDel Concepts Restaurants Turn Girl Scout Cookies into Innovative Dess
Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd
Investors will be All Ears to Janet Yellen as she Testifies before the US Senate
Proposed Merger of Sysco and US Foods faces Strong Opposition
Procter & Gamble to Discontinue About Hundred of Its Brands by Summer
An Entrepreneur Predicts: Apple will buy Tesla Motors in Eighteen Months
A Federal Judge in the U.S Finds American Express Guilty Of Antitrust Violations
First Phase of Repair of the Washington National Cathedral has Finished